Search Results - "Mire, Chad"

Refine Results
  1. 1

    Post-exposure treatments for Ebola and Marburg virus infections by Cross, Robert W., Mire, Chad E., Feldmann, Heinz, Geisbert, Thomas W.

    Published in Nature reviews. Drug discovery (01-06-2018)
    “…Key Points The filoviruses, Ebola virus and Marburg virus, cause lethal haemorrhagic fever in humans and non-human primates (NHPs), and there are currently no…”
    Get full text
    Journal Article
  2. 2

    Current Ebola Virus Vaccine Progress by Marzi, Andrea, Mire, Chad E.

    “…Over 40 years since the discovery of Ebola virus, the anti-Ebola virus vaccine efforts of the past 2 decades have culminated in over 12 different vaccine…”
    Get full text
    Journal Article
  3. 3

    Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates by Thi, Emily P., Mire, Chad E., Lee, Amy C. H., Geisbert, Joan B., Zhou, Joy Z., Agans, Krystle N., Snead, Nicholas M., Deer, Daniel J., Barnard, Trisha R., Fenton, Karla A., MacLachlan, Ian, Geisbert, Thomas W.

    Published in Nature (London) (21-05-2015)
    “…Ebola-virus-targeting short interfering RNAs (siRNAs) encapsulated in lipid nanoparticles are adapted to the current outbreak strain of the virus, and the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome by Luthra, Priya, Ramanan, Parameshwaran, Mire, Chad E., Weisend, Carla, Tsuda, Yoshimi, Yen, Benjamin, Liu, Gai, Leung, Daisy W., Geisbert, Thomas W., Ebihara, Hideki, Amarasinghe, Gaya K., Basler, Christopher F.

    Published in Cell host & microbe (17-07-2013)
    “…The cytoplasmic pattern recognition receptor RIG-I is activated by viral RNA and induces type I IFN responses to control viral replication. The cellular dsRNA…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses by Pécheur, Eve-Isabelle, Borisevich, Viktoriya, Halfmann, Peter, Morrey, John D, Smee, Donald F, Prichard, Mark, Mire, Chad E, Kawaoka, Yoshihiro, Geisbert, Thomas W, Polyak, Stephen J

    Published in Journal of virology (06-01-2016)
    “…Arbidol (ARB) is a synthetic antiviral originally developed to combat influenza viruses. ARB is currently used clinically in several countries but not in North…”
    Get full text
    Journal Article
  8. 8

    Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus by Mire, Chad E, Geisbert, Joan B, Marzi, Andrea, Agans, Krystle N, Feldmann, Heinz, Geisbert, Thomas W

    Published in PLoS neglected tropical diseases (01-12-2013)
    “…Ebola virus (EBOV) causes severe and often fatal hemorrhagic fever in humans and nonhuman primates (NHPs). Currently, there are no licensed vaccines or…”
    Get full text
    Journal Article
  9. 9

    Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever by Rodriguez, Sergio E., Cross, Robert W., Fenton, Karla A., Bente, Dennis A., Mire, Chad E., Geisbert, Thomas W.

    Published in Scientific reports (23-05-2019)
    “…Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne bunyavirus, can cause a life-threatening hemorrhagic syndrome in humans but not in its animal host…”
    Get full text
    Journal Article
  10. 10

    Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System by Levine, Corri B, Mire, Chad E, Geisbert, Thomas W

    Published in Journal of virology (27-09-2021)
    “…Members of the genus cause lethal disease in humans, with (EBOV) being the most pathogenic (up to 90% morality) and ebolavirus (BDBV) the least pathogenic…”
    Get full text
    Journal Article
  11. 11

    A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses by Safronetz, David, Mire, Chad, Rosenke, Kyle, Feldmann, Friederike, Haddock, Elaine, Geisbert, Thomas, Feldmann, Heinz

    Published in PLoS neglected tropical diseases (01-04-2015)
    “…Lassa virus (LASV) is endemic in several West African countries and is the etiological agent of Lassa fever. Despite the high annual incidence and significant…”
    Get full text
    Journal Article
  12. 12

    The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus by Cross, Robert W., Mire, Chad E., Borisevich, Viktoriya, Geisbert, Joan B., Fenton, Karla A., Geisbert, Thomas W.

    Published in The Journal of infectious diseases (15-08-2016)
    “…Small-animal models have been developed for several Filoviridae species; however, serial adaptation was required to produce lethal infection. These adapted…”
    Get full text
    Journal Article
  13. 13

    The immunomodulating V and W proteins of Nipah virus determine disease course by Satterfield, Benjamin A., Cross, Robert W., Fenton, Karla A., Agans, Krystle N., Basler, Christopher F., Geisbert, Thomas W., Mire, Chad E.

    Published in Nature communications (24-06-2015)
    “…The viral determinants that contribute to Nipah virus (NiV)-mediated disease are poorly understood compared with other paramyxoviruses. Here we use recombinant…”
    Get full text
    Journal Article
  14. 14

    Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates by Mire, Chad E, Geisbert, Joan B, Agans, Krystle N, Satterfield, Benjamin A, Versteeg, Krista M, Fritz, Elizabeth A, Feldmann, Heinz, Hensley, Lisa E, Geisbert, Thomas W

    Published in PloS one (01-04-2014)
    “…The filoviruses, Marburg virus (MARV) and Ebola virus, causes severe hemorrhagic fever with high mortality in humans and nonhuman primates. A promising…”
    Get full text
    Journal Article
  15. 15

    Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease by Mire, Chad E, Geisbert, Joan B, Agans, Krystle N, Versteeg, Krista M, Deer, Daniel J, Satterfield, Benjamin A, Fenton, Karla A, Geisbert, Thomas W

    Published in Emerging infectious diseases (01-06-2019)
    “…Nipah virus (NiV) is a zoonotic pathogen that causes high case-fatality rates (CFRs) in humans. Two NiV strains have caused outbreaks: the Malaysia strain (NiV…”
    Get full text
    Journal Article
  16. 16

    An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections by Dang, Ha V., Chan, Yee-Peng, Park, Young-Jun, Snijder, Joost, Da Silva, Sofia Cheliout, Vu, Bang, Yan, Lianying, Feng, Yan-Ru, Rockx, Barry, Geisbert, Thomas W., Mire, Chad E., Broder, Christopher C., Veesler, David

    Published in Nature structural & molecular biology (01-10-2019)
    “…Nipah virus (NiV) and Hendra virus (HeV) are zoonotic henipaviruses (HNVs) responsible for outbreaks of encephalitis and respiratory illness with fatality…”
    Get full text
    Journal Article
  17. 17

    The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus by Jasenosky, Luke D., Cadena, Cristhian, Mire, Chad E., Borisevich, Viktoriya, Haridas, Viraga, Ranjbar, Shahin, Nambu, Aya, Bavari, Sina, Soloveva, Veronica, Sadukhan, Supriya, Cassell, Gail H., Geisbert, Thomas W., Hur, Sun, Goldfeld, Anne E.

    Published in iScience (27-09-2019)
    “…Here, we show that the US Food and Drug Administration-approved oral drug nitazoxanide (NTZ) broadly amplifies the host innate immune response to viruses and…”
    Get full text
    Journal Article
  18. 18

    Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy by Mire, Chad E., Satterfield, Benjamin A., Geisbert, Joan B., Agans, Krystle N., Borisevich, Viktoriya, Yan, Lianying, Chan, Yee-Peng, Cross, Robert W., Fenton, Karla A., Broder, Christopher C., Geisbert, Thomas W.

    Published in Scientific reports (03-08-2016)
    “…Nipah virus (NiV) is a paramyxovirus that causes severe disease in humans and animals. There are two distinct strains of NiV, Malaysia (NiV M ) and Bangladesh…”
    Get full text
    Journal Article
  19. 19

    The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway by Edwards, Megan R, Johnson, Britney, Mire, Chad E, Xu, Wei, Shabman, Reed S, Speller, Lauren N, Leung, Daisy W, Geisbert, Thomas W, Amarasinghe, Gaya K, Basler, Christopher F

    Published in Cell reports (Cambridge) (01-03-2014)
    “…Kelch-like ECH-associated protein 1 (Keap1) is a ubiquitin E3 ligase specificity factor that targets transcription factor nuclear factor (erythroid-derived…”
    Get full text
    Journal Article
  20. 20

    The Mucin-Like Domain of the Ebola Glycoprotein Does Not Impact Virulence or Pathogenicity in Ferrets by Halfmann, Peter J, Borisevich, Viktoriya, Levine, Corri B, Mire, Chad E, Fenton, Karla A, Geisbert, Thomas W, Kawaoka, Yoshihiro, Cross, Robert W

    Published in The Journal of infectious diseases (15-11-2023)
    “…Abstract Background Ebola virus (EBOV) is considered among the most dangerous viruses with case fatality rates approaching 90% depending on the outbreak. While…”
    Get full text
    Journal Article